SCHEMBL23549436

SCHEMBL23549436

COc1cc(C(O)C[N+](=O)[O-])ccc1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.64
TSHR P16473 2/20 0.63
CYP3A4 P08684 1/20 0.63
NFKB1 P19838 1/20 0.61
BLM P54132 2/20 0.60
PMP22 Q01453 1/20 0.60
SLC22A3 O75751 1/20 0.56
ALDH1A1 P00352 5/20 0.54
MAPT P10636 4/20 0.54
GAA P10253 3/20 0.54
HTT P42858 2/20 0.54
NPSR1 Q6W5P4 2/20 0.54
MEN1 O00255 1/20 0.53
PKM P14618 1/20 0.53
KMT2A Q03164 1/20 0.53
KDM4E B2RXH2 1/20 0.50
CYP2C19 P33261 1/20 0.50
STAT3 P40763 1/20 0.47
GALR2 O43603 1/20 0.47
EGFR P00533 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5518745 0.88 ALDH1A1 (0.63) LMNATSHRCYP3A4NFKB1BLM
SCHEMBL5525324 0.88 ALDH1A1 (0.63) LMNATSHRCYP3A4NFKB1BLM
SCHEMBL17357757 0.85 ALDH1A1 (0.50) LMNATSHRCYP3A4NFKB1BLM
SCHEMBL5533675 0.81 ALDH1A1 (0.59) LMNATSHRCYP3A4NFKB1BLM
SCHEMBL29761292 0.79 TSHR (0.77) TSHRCYP3A4NFKB1BLMPMP22
SCHEMBL8082807 0.79 TSHR (0.77) TSHRCYP3A4NFKB1BLMPMP22
SCHEMBL43536 0.78 TSHR (1.00) TSHRCYP3A4NFKB1BLMPMP22
SCHEMBL31364250 0.78 TSHR (1.00) TSHRCYP3A4NFKB1BLMPMP22
SCHEMBL31254076 0.78 TSHR (1.00) TSHRCYP3A4NFKB1BLMPMP22
SCHEMBL29776919 0.78 TSHR (1.00) TSHRCYP3A4NFKB1BLMPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11045792-B1 Highly efficient nanosized mesoporous CuMgAl ternary oxide catalyst KING ABDULAZIZ UNIVERSITY (SA) 2021-06-29 US claimed
US-11045792-B1 Highly efficient nanosized mesoporous CuMgAl ternary oxide catalyst KING ABDULAZIZ UNIVERSITY (SA) 2021-06-29 US disclosed
US-11045792-B1 Highly efficient nanosized mesoporous CuMgAl ternary oxide catalyst KING ABDULAZIZ UNIVERSITY (SA) 2021-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11045792-B1 Highly efficient nanosized mesoporous CuMgAl ternary oxide catalyst SOD1, SOD3, CUL3 LMNA 4076/4885TSHR 4354/4885CYP3A4 386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.